710
T. Schoetzau et al.
PAPER
spectra were obtained on a IR-408 (Shimadzu, Japan), and 1600 se-
ries (Perkin Elmer, USA). HPLC was performed using pump-sys-
tem LC 1110, System Organiser LC 1431, UV-Detectors GAT-
PHD 601, GATZ LCD 502 (Gamma Analysen Technik, Germany),
Mono Q (Pharmacia). UV/VIS-spectra were obtained on a Spekord
UV 160 A (Shimadzu, Japan). NMR spectra were obtained on an
DPX 300 and AMX 600 spectrometer (Bruker Physics AG, USA).
Coupling constants (J) are given in Hz, and all chemical shifts are
relative to an internal standard of TMS (1H and 13C) or with 85%
phosphoric acid as an external standard (31P). Mass spectra were ob-
tained on a FAB-MS (SSQ 7000), EI-MS (MAT 90), and MALDI-
TOF-MS (Voyager DE-STR).
(C3¢), 39.66 (C2¢), 41.84, 42.08 (2 x CH2), 65.74 (C5¢), 86.54 (C4¢),
87.66 (C1¢), 111.70 (C5), 128.97 (olefin), 132.41 (olefin), 129.39-
137.11 (12C, Ar), 137.96 (C6), 152.82 (C2), 166.88 (C4), 176.95
(C=O).
MALDI-TOF-MS: m/z calc for (M+H)+ 633.35. Found: 633.53.
5¢-O-TBDPS-3¢-C-[N-[N-(2-trifluoracetylaminoethyl)]-6-car-
bamoylhex-2(Z)-enyl]-3¢-deoxythymidine (4)
The nucleoside 3 (0.20 g, 0.32 mmol) was dissolved in CH2Cl2
(5 mL) and Et3N (1.3 mL), cooled in an ice bath, and trifluoroacetic
anhydride (0.053 mL, 0.38 mmol) was added dropwise. The solu-
tion was stirred for 1 h in the ice bath, evaporated to dryness, and
purified by column chromatography on silica gel with CHCl3. The
product 4 (0.22 mg, 95%) was obtained as a solid white foam.
1H NMR (300 MHz, CDCl3): d = 1.02 (s, 9H, C(CH3)3), 1.52 (s, 3H,
C5-CH3), 1.62 (q, 2H, J = 7.5, CH2), 1.83-2.22 (m, 8H, H-2¢,
3 x CH2), 2.35 (m, 1H, H-3¢), 3.38 (br s, 4H, 2 x NCH2), 3.71 (m,
2H, H-4¢, H-5¢a), 3.96 (dd, 1H, J5¢a,5¢b = -11.5, J5¢b,4¢ = 2.0, H-5¢b),
5.26 (m, 1H, olefin), 5.36 (m, 1H, olefin), 6.02 (t, 1H, J = 6.0, H-1¢),
7.29-7.60 (m, 11H, ArH, H-6), 8.31 (br s, 1H, NH).
13C NMR (75 MHz, CDCl3): d = 12.03 (C5-CH3), 19.32 (-C(CH3)3),
25.34, 26.86 (2 x CH2), 26.92 (-C(CH3)3), 35.71, 37.60 (2 x CH2),
38.29 (C3¢), 38.34 (C2¢), 41.18, 43.35 (2 x CH2), 64.66 (C5¢), 85.07
(C4¢), 85.59 (C1¢), 110.76 (C5), 113.94 (-CF3), 127.01 (olefin),
129.94 (olefin), 127.83-135.66 (12C, Ar), 135.46 (C6), 150.83
(C2), 157.54 (COCF3), 164.65 (C4), 175.06 (C=O).
5¢-O-TBDPS-3¢-C-(6-carboxyhex-2(Z)-enyl)-3¢-deoxythymi-
dine (2)
(4-Carboxybutyl)triphenylphosphonium
bromide
(2.62 g,
5.92 mmol) was dissolved in dry THF (23 mL). The vessel was
closed with a septum, and a low pressure of Ar was maintained. Into
the vessel, 1 M NaN(TMS)2 (12.82 mL, 12.82 mmol) in THF was
injected through a septum. The formation of the orange-red ylide
was finished after 15 min. The aldehyde 1 (1.0 g, 1.97 mmol), dis-
solved in dry THF (2 mL), was then injected into the well-stirred so-
lution of the ylide. After 15 min, the reaction mixture was poured
into CHCl3 (500 mL) and extracted with 5% HCl (500 mL), and
brine (500 mL). The organic layer was dried (Na2SO4). Removal of
the solvent in vacuo afforded an oily residue, which was purified by
column chromatography on silica gel with CHCl3/MeOH (0-10%
MeOH). The product 2 (0.79 g, 68%) was obtained as a solid white
foam.
19F NMR (282 MHz, CDCl3): d = -76.30.
1H NMR (300 MHz, CDCl3): d = 1.02 (s, 9H, C(CH3)3), 1.53 (s, 3H,
C5-CH3), 1.61 (q, 2H, J = 7.2, CH2), 1.91-2.10 (m, 6H, H-2¢,
2 x CH2), 2.24 (t, 2H, J = 7.2, CH2), 2.32 (m, 1H, H-3¢), 3.69 (m,
2H, H-4¢, H-5¢a), 3.95 (dd, 1H, J5¢a,5¢b = -12.5, J5¢b,4¢ = 3.2, H-5¢b),
5.23 (m, 1H, olefin), 5.30 (m, 1H, olefin), 6.05 (t, 1H, J = 5.3, H-1¢),
7.28-7.61 (m, 11H, ArH, H-6), 10.03 (br s, 1H, NH).
13C NMR (75 MHz, CDCl3): d = 11.96 (C5-CH3), 19.29 (-C(CH3)3),
26.48 (CH2), 26.91 (-C(CH3)3), 29.48, 30.51, 33.23 (3 x CH2), 37.47
(C3¢), 38.56 (C2¢), 63.79 (C5¢), 84.72 (C4¢), 85.67 (C1¢), 110.42
(C5), 127.02 (olefin), 130.88 (olefin), 127.75-135.39 (12C, Ar),
135.75 (C6), 150.57 (C2), 164.67 (C4), 177.63 (C=O).
3¢-C-[N-[N-(2-Trifluoracetylaminoethyl)]-6-carbamoylhex-
2(Z)-enyl]-3¢-deoxythymidine (5)
The nucleoside 4 (0.20 mg, 0.27 mmol) was dissolved in dry THF
(2 mL). A solution of 1 M Bu4NF (TBAF) (0.30 mL, 0.30 mmol) in
THF was added. The reaction was completed after 1 h. The solvent
was evaporated in vacuo. The residue was dissolved in CHCl3
(50 mL) and extracted twice with H2O (50 mL). The organic layer
was dried (NaSO4), and the solvent was removed under reduced
pressure. The resulting syrup was chromatographed over silica gel
with CHCl3. The compound 5 (0.11 mg, 82%) was obtained as a sol-
id colorless product.
1H NMR (300 MHz, CD3OD): d = 1.77 (s, 3H, C5-CH3), 1.88-2.19
(m, 10H, H-2¢, 4 x CH2), 2.22 (m, 1H, H-3¢), 3.28 (m, 4H, 2 x
NCH2), 3.63 (m, 2H, H-4¢, H-5¢a), 3.81 (dd, 1H, J5¢a,5¢b = -13.6,
MALDI-TOF-MS: m/z calc for (M+H)+ 591.29. Found: 591.02.
5¢-O-TBDPS-3¢-C-[N-(2-aminoethyl)-6-carbamoylhex-2(Z)-
enyl]-3¢-deoxythymidine (3)
J
5¢b,4¢ = 3.4, H-5¢b), 5.34 (m, 2H, olefin), 5.95 (dd, 1H, J1¢,2¢a = 4.0,
J1¢,2¢b = 6.0, H-1¢), 7.90 (s, 1H, H-6).
A mixture of 2 (0.47 g, 0.79 mmol), diisopropyl ethyl amine
(0.40 mL, 2.3 mmol), and N,N,N¢,N¢-tetramethyl-O-succinimidou-
ronium tetrafluoroborate (TSTU, 0.29 mg, 0.95 mmol) was dis-
solved in dioxane (1.5 mL) and DMF (1.5 mL). The activation of
the free carboxylic acid 2 was completed after 20 min and could be
observed on TLC. Freshly distilled ethylenediamine (0.21 mL, 3.17
mmol) was added. The reaction was completed at r.t. after 10 min.
The resulting suspension was evaporated to dryness, dissolved in
CHCl3 (100 mL), and extracted with sat. NaHCO3 (100 mL). The
organic phase was separated, dried (Na2SO4), and evaporated again
to dryness. The resulting residue was purified by column chroma-
tography on silica gel with CHCl3/MeOH (0-15% MeOH). The
product 3 (0.22 mg, 43%) was obtained as a colorless oil.
13C NMR (75 MHz. CD3OD): d = 12.93 (C5-CH3), 25.18, 27.00,
33.41, 36.86 (4 x CH2), 38.71 (C3¢), 39.68 (C2¢), 40.16, 40.94 (2 x
CH2), 62.86 (C5¢), 86.75 (C4¢), 88.21 (C1¢), 111.17 (C5), 116.24
(CF3), 128.95 (olefin), 132.28 (olefin), 138.88 (C6), 152.75 (C2),
158.00 (-COCF3), 166.95 (C4), 176.93 (C=O).
19F NMR (282 MHz, CD3OD): d = -77.72.
HRMS (FAB-MS): m/z calc for C21H29F3N4O6 (M+H)+ 491.2117.
Found: 491.2115.
5¢-O-TBDPS-3¢-C-[N-[N-(6-trifluoroacetylaminohexyl)]-6-car-
bamoylhex-2(Z)-enyl]-3¢-deoxythymidine (6)
1H NMR (300 MHz, CDCl3): d = 0.98 (s, 9H, C(CH3)3), 1.42 (s, 3H,
C5-CH3), 1.55 (q, 2H, J = 7.4, CH2), 1.90-2.14 (m, 8H, H-2¢, 3 x
CH2), 2.37 (m, 1H, H-3¢), 2.72 (t, 2H, J = 6.2, NCH2), 3.20 (t, 2H,
J = 6.2, NCH2), 3.71 (m, 2H, H-4¢, H-5¢a), 3.95 (dd, 1H, J5¢a,5¢b = -
11.5, J5¢b,4¢ = 2.0, H-5¢b), 5.33 (m, 2H, olefin), 5.99 (dd, 1H,
The nucleoside 2 (0.26 g, 0.44 mmol), diisopropyl ethyl amine
(0.24 mL, 1.41 mmol), and TSTU (0.16 g, 0.53 mmol) were dis-
solved in dioxane (0.82 mL) and DMF (0.82 mL). The activation of
the free carboxylic acid 2 was completed within 20 min. The N-tri-
fluoracetyl-1,6-diaminohexane (0.11 g, 0.58 mmol) was added at
r.t. and stirred for 30 min. The solvent was evaporated in vacuo. The
residue was dissolved in 50 mL CHCl3, and extracted with aq
NaHCO3 (50 mL). The organic layer was seperated, dried (Na2SO4),
and the solvent was removed under reduced pressure. The resulting
J
1¢,2¢a = 6.6, J1¢,2¢b = 4.7, H-1¢), 7.25-7.77 (m, 11H, ArH, H-6).
13C NMR (75 MHz, CDCl3): d = 12.84 (C5-CH3), 20.73 (-C(CH3)3),
27.71 (CH2), 28.03 (-C(CH3)3), 28.31, 33.54, 36.92 (3 x CH2), 39.44
Synthesis 2000, No. 5, 707–713 ISSN 0039-7881 © Thieme Stuttgart · New York